Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 2 May

Sophia Mavridis
May 2, 2023

Morning Bell 1 May

Sophia Mavridis
May 1, 2023

Weekly Wrap 28 April

Sophia Mavridis
April 28, 2023

Morning Bell 28 April

Sophia Mavridis
April 28, 2023

Morning Bell 27 April

Grady Wulff
April 27, 2023

Morning Bell 26 April

Grady Wulff
April 26, 2023

Morning Bell 24 April

Grady Wulff
April 24, 2023

Weekly Wrap 21 April

Grady Wulff
April 21, 2023

Morning Bell 21 April

Sophia Mavridis
April 21, 2023

Morning Bell 20 April

Grady Wulff
April 20, 2023

Morning Bell 19 April

Grady Wulff
April 19, 2023

Morning Bell 18 April

Sophia Mavridis
April 18, 2023